bluebird bio (BLUE) Reports Q1 Loss of $3.64/sh

bluebird bio (NASDAQ: BLUE) reported Q1 EPS of ($3.64), versus ($2.99) reported last year. Revenue for the quarter came in at $21.9 million, versus $12.5 million reported last year.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• CVG to join Russell 2000 and Russell 3000 indexes June 26
• Ennis (EBF) Reports In-Line Q1 EPS